![]() 双(4-氯苯氧基)乙酸结构式
![]() |
常用名 | 双(4-氯苯氧基)乙酸 | 英文名 | 2,2-bis(4-chlorophenoxy)acetic acid |
---|---|---|---|---|
CAS号 | 29815-94-9 | 分子量 | 313.13300 | |
密度 | 1.441g/cm3 | 沸点 | 464ºC at 760 mmHg | |
分子式 | C14H10Cl2O4 | 熔点 | 138-140ºC(lit.) | |
MSDS | 美版 | 闪点 | 234.4ºC | |
符号 |
![]() GHS07 |
信号词 | Warning |
[Impact of infusion therapy on the indices of endogenous intoxication in severe combined trauma of the abdominal organs].
Klin. Khir. (2) , 67-70, (2013) The peculiarities of course of endogenous intoxication (EI) in severe combined abdominal trauma were studied up in experiment. There was established, that in the laboratory animals, to whom the blood loss compensation was done, using colloid-hyperosmolar solu... |
|
[Using solutions of hydroxyethyl starch (6% HES 200/0.5 (refortan) and 6% HES 130/0.4 (voluven)) in neuroanesthesiology].
Anesteziol. Reanimatol. (2) , 27-30, (2008) The paper provides the results of a complex experimental and clinical study of the effects of infusion solutions of hydroxyethyl starch (HES 200/0.5--Refortan and HES 130/0.4--Voluven) on hemostatic and systemic hemodynamic parameters in patients operated on ... |
|
[Experience with using of solutions of hydroxyethyl starch (refortan and voluven) in neuroanesthesiology].
Vestn. Khir. Im. I. I. Grek. 166(6) , 56-60, (2007) The investigation has shown that solutions of hydroxyethyl starch included in complex infusion therapy facilitate stabilization of hemodynamics in neurosurgical patients during surgery. Refortan exerts a more pronounced effect on the indices of hemodynamics a... |
|
[Comparative evaluation of different infusion medias used in therapy for neonatal hypovolemia].
Anesteziol. Reanimatol. (1) , 32-5, (2005) The paper comparatively evaluates the efficiency of the use of physiological sodium chloride solution, freshly-frozen plasma, 6% and 10% solutions of hydroxyethyl starch to compensate for circulating blood volume deficit in 80 neonatal infants aged 1-3 days w... |
|
Prospective observational study for perioperative volume replacement with 6% HES 130/0,42, 4% gelatin and 6% HES 200/0,5 in cardiac surgery.
Eur. J. Med. Res. 15(9) , 383-9, (2010) the constantly growing amount of different kinds of colloid fluids necessitates comparative investigations with regards to the safety and effectivity in clinical use of these preparations. Hence we compared three colloid fluids in an observational study. The ... |